At a glance
Moderate Complexity
The PRISM grant is designed to help modernize how the FDA oversees public health by supporting collaborations that improve regulatory processes. This is important because as new medical products and technologies develop, the FDA needs to ensure they are safe and effective for the public. The grant encourages partnerships with various groups to create new scientific tools and methods that make regulation more predictable and efficient.
Who it's for: This grant is for organizations that can collaborate on projects to modernize regulatory science. It could include partnerships with patients, consumers, industry professionals, academic institutions, and healthcare workers.
More details
Likely Disqualifiers
- Not aligning with the FDA's strategic priorities
- Proposing regulatory (rather than non-regulatory) projects
- Lack of collaboration with eligible groups
- Failure to demonstrate potential for real-world impact
- Incomplete application submission
What You May Need
- Detailed project proposal
- Partnership agreements
- Evidence of alignment with FDA priorities
- Budget plan
- Organizational information
- Proof of eligibility
- Past performance documentation
- Letters of support
- Timeline for project execution
Cautions
- Ensure alignment with FDA's strategic priorities
- Focus on non-regulatory collaborations
- Prepare for competitive application process